Mitsubishi UFJ Trust & Banking Corp Sells 21,839 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mitsubishi UFJ Trust & Banking Corp lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 208,585 shares of the company’s stock after selling 21,839 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in HCA Healthcare were worth $62,607,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Congress Wealth Management LLC DE raised its position in HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC boosted its position in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares in the last quarter. Mediolanum International Funds Ltd increased its holdings in shares of HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after purchasing an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. grew its position in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after buying an additional 40 shares during the period. Finally, Whittier Trust Co. raised its position in shares of HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after acquiring an additional 41 shares during the period. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Barclays reduced their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Bank of America dropped their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Stock Up 0.7 %

HCA stock opened at $336.12 on Wednesday. The firm’s 50 day moving average price is $322.63 and its 200-day moving average price is $341.89. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market cap of $82.75 billion, a PE ratio of 15.30, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business posted $5.90 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.